These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11434814)

  • 1. From the Food and Drug Administration.
    Schwetz BA
    JAMA; 2001 Jul; 286(1):35. PubMed ID: 11434814
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic myeloid leukemia. Sceptical scientists.
    Druker BJ
    Lancet; 2001 Dec; 358 Suppl():S11. PubMed ID: 11784560
    [No Abstract]   [Full Text] [Related]  

  • 3. Imatinib mesylate.
    Am J Health Syst Pharm; 2001 Dec; 58(23):2241-2. PubMed ID: 11765724
    [No Abstract]   [Full Text] [Related]  

  • 4. Gleevec for the treatment of chronic myelogenous leukemia: US. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug status.
    Cohen MH; Moses ML; Pazdur R
    Oncologist; 2002; 7(5):390-2. PubMed ID: 12401900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STI571: a magic bullet?
    Verweij J; Judson I; van Oosterom A
    Eur J Cancer; 2001 Oct; 37(15):1816-9. PubMed ID: 11576833
    [No Abstract]   [Full Text] [Related]  

  • 6. A hope for the future.
    Silver RT
    Cancer Invest; 2003 Jun; 21(3):486. PubMed ID: 12901295
    [No Abstract]   [Full Text] [Related]  

  • 7. Disabling Abl-perspectives on Abl kinase regulation and cancer therapeutics.
    Sawyers CL
    Cancer Cell; 2002 Feb; 1(1):13-5. PubMed ID: 12086882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STI571 (glivec-tm): a new paradigm for the development of innovative therapies in onco-hematology?
    Gambacorti C
    Tumori; 2001; 87(6):S10-2. PubMed ID: 11989608
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug developers unveil strategies aimed at imatinib-resistant CML.
    Goozner M
    J Natl Cancer Inst; 2010 May; 102(9):593-5. PubMed ID: 20421566
    [No Abstract]   [Full Text] [Related]  

  • 11. Implications of signal transduction inhibition for the treatment of chronic myeloid leukemia.
    Sawyers CL
    Semin Hematol; 2001 Jul; 38(3 Suppl 8):1-2. PubMed ID: 11526594
    [No Abstract]   [Full Text] [Related]  

  • 12. 3. Imatinib therapy in chronic myelogenous leukemia.
    Jinnai I
    Intern Med; 2007; 46(2):95-7. PubMed ID: 17220607
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic myeloid leukemia and imatinib mesylate therapy].
    Chrobák L
    Vnitr Lek; 2004 Jan; 50(1):10-2. PubMed ID: 15015223
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigator profile. Brian J. Druker, M.D. Interview by Vicki P. Glaser.
    Druker BJ
    J Hematother Stem Cell Res; 2001 Dec; 10(6):721-4. PubMed ID: 11798498
    [No Abstract]   [Full Text] [Related]  

  • 15. Decrease of resistance to imatinib in leukaemia.
    Bakalova R; Zhelev Z; Ohba H
    Lancet; 2002 May; 359(9319):1776-7. PubMed ID: 12049890
    [No Abstract]   [Full Text] [Related]  

  • 16. CML: imatinib mesylate (Glivec) or something else?
    Ghosh A
    Nepal Med Coll J; 2007 Dec; 9(4):292. PubMed ID: 18298026
    [No Abstract]   [Full Text] [Related]  

  • 17. STI571 (Gleevec) as a paradigm for cancer therapy.
    Druker BJ
    Trends Mol Med; 2002; 8(4 Suppl):S14-8. PubMed ID: 11927282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thriving with chronic myeloid leukaemia.
    Morris RH
    Lancet; 2001 Dec; 358 Suppl():S12. PubMed ID: 11784561
    [No Abstract]   [Full Text] [Related]  

  • 19. After 30 years of laboratory work, a quick approval for STI571.
    Arnold K
    J Natl Cancer Inst; 2001 Jul; 93(13):972. PubMed ID: 11438558
    [No Abstract]   [Full Text] [Related]  

  • 20. Taking aim at Ewing's sarcoma: is KIT a target and will imatinib work?
    Druker BJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1660-1. PubMed ID: 12441314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.